Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...

Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...

Abivax shares surged 500% after positive phase 3 results for obefazimod in moderate-to-severe ulcerative colitis. Click here ...

How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...

Fragile X disorders include two distinct conditions: fragile X syndrome (the most common single-gene cause of developmental ...

A group of University of Ottawa researchers have already shown how scientists can harness gene therapies to deliver ...

Liquid biopsies have transformed cancer testing. These tests detect signs of cancer using a simple blood draw instead of ...

A team of researchers testing an experimental messenger RNA (mRNA) vaccine managed to ramp up the ability of immunotherapy to combat tumors in a stu ...

While a one-stop shop still has its advantages, sponsor companies and CDMOs are starting to see each other not as ...

Two months after laying off 20% of its staff, Korro Bio says it has not retreated from its “3-2-1” corporate strategy as it prepares to release interim clinical data on its lead candidate KRRO-110 in ...

A group of scientists from the Angiogenesis Unit of the Biomedical Research Centre of La Rioja (CIBIR) has succeeded in creating a vaccine, based on messenger RNA technology, that ...

New research published in the Journal of Psychopharmacology has found that a single dose of psilocybin leads to widespread ...